Immunine

Human coagulation factor IX, the active ingredient in Immunine, is a coagulation factor presented as a sterile solution for intravenous use. It replaces deficient factor IX to manage hemophilia B and acquired factor IX deficiency in patients with bleeding disorders.

GNH USA supplies Immunine as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Immunine is used to correct deficiencies in the intrinsic coagulation pathway associated with factor IX deficiency. - Hemophilia B: restores clotting ability and reduces bleeding episodes. - Acquired factor IX deficiency: provides temporary replacement to control hemorrhage. - Peri‑operative management in known factor IX deficiency: ensures adequate hemostasis during surgery.

Immunine may be associated with infusion‑related reactions and immunogenic responses.

Common Side Effects: - Fever - Headache - Nausea - Injection‑site erythema - Mild hypotension - Transient arthralgia

Serious or Rare Side Effects: - Development of neutralizing inhibitors against factor IX - Anaphylactic or severe allergic reactions - Thromboembolic events - Hemolysis - Severe hypertension

Before using Immunine, consider the following precautions: - Dose adjustment: individualize based on factor IX activity levels and clinical response. - Bleeding risk monitoring: assess for signs of uncontrolled bleeding. - Inhibitor testing: screen for development of anti‑factor IX antibodies. - Renal or hepatic impairment: use with caution and monitor organ function. - Pregnancy and lactation: limited data; weigh benefits against potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Immunine can interact with other agents that affect coagulation.

Major Interactions (Avoid): - Concomitant use of pro‑coagulant concentrates may increase thrombosis risk. - Combined use with antifibrinolytics (e.g., tranexamic acid) can potentiate clot formation and requires careful monitoring.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., beta‑lactams) may alter immune response; monitor for inhibitor development. - Live vaccines may have reduced efficacy; schedule appropriately. - Co‑administration with other plasma‑derived products may increase volume load; monitor fluid status.